Related Experiment Video
Updated: Mar 6, 2026

08:42
A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
8.9K
ASPIRE-Med project: a study protocol on an Australian psychotropic medicines training programme for disability
Macey Barratt1,2, Kathryn Speer3,2, Shoumitro Deb4
1Centre for Ageing Research and Translation, University of Canberra, Bruce, Australian Capital Territory, Australia Macey.Barratt@canberra.edu.au.
BMJ Open
|March 4, 2026
Summary
This project protocol outlines a training program for disability support workers (DSWs) on appropriate psychotropic medicine use in individuals with intellectual and developmental disabilities. The training aims to enhance DSWs
Area of Science:
- Intellectual and Developmental Disabilities
- Psychopharmacology
- Healthcare Workforce Training
Background:
- Overmedication of psychotropic medicines for behaviors of concern in individuals with intellectual and developmental disabilities (IDD) is a significant public health issue.
- Disability Support Workers (DSWs) are crucial in managing psychotropic medication for adults with IDD.
- There is a critical need for targeted DSW training on the appropriate use of these medications.
Purpose of the Study:
- To develop a comprehensive training program for DSWs focused on the appropriate use of psychotropic medicines in individuals with IDD.
- To improve DSWs' knowledge, confidence, and skills in managing psychotropic medications and supporting individuals with IDD.
Main Methods:
- A participatory action framework and Universal Design for Learning approach will guide program development.
- Co-production involving people with IDD, families, DSWs, healthcare professionals, and educational designers.
- Key steps include needs analysis, literature review, focus groups, co-design events, field testing, a feasibility trial with a train-the-trainer model, and mixed-method process evaluation.
Main Results:
- The training is expected to improve DSWs' knowledge of appropriate psychotropic prescribing for individuals with IDD.
- Enhanced confidence in communication with healthcare professionals and application of non-pharmacological strategies.
- Promotion of shared decision-making, advocacy for medication reviews, and positive interactions.
Conclusions:
- The developed training program aims to equip DSWs with essential skills for appropriate psychotropic medicine management in IDD.
- The program's co-production and dissemination across Australia, offered free to DSWs, ensures broad accessibility.
- Successful implementation is anticipated to positively influence client outcomes and support practices for individuals with IDD.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
645
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
645
Blind Procedures
13.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.8K
Drug Therapy
346
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
346

